← Back to Search

Device

High Frequency SARS for Spinal Cord Injury (SARS600 Trial)

Phase < 1
Waitlist Available
Led By Dennis Bourbeau, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Suprasacral SCI
Neurologically stable
Must not have
Significant urethral trauma, erosion, or stricture
Bleeding diathesis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new electrical stimulation pattern to help people with spinal cord injuries empty their bladders. The treatment uses electrical signals to relax the muscle that controls urine release. It aims to help these individuals urinate without needing additional surgeries or catheters. Electrical stimulation has been used historically to treat bladder dysfunction by causing muscle contraction and modulating central nervous system functions.

Who is the study for?
This trial is for adults with spinal cord injury who already use a SARS System to manage bladder function. They should be neurologically stable and not have any major urethral damage, active infections, open sores near the pelvis, or bleeding disorders.
What is being tested?
The study tests if stimulating sacral roots at certain frequencies can help empty the bladder without cutting nerves. Participants with an implanted device will try new stimulation patterns aimed at relaxing the sphincter to improve bladder emptying.
What are the potential side effects?
Potential side effects may include discomfort from electrical stimulation and possible irritation at the site of implantation. There might also be risks related to changes in bladder or bowel function due to altered nerve stimulation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My spinal cord injury is above my lower back.
Select...
My neurological condition is stable.
Select...
My bones have stopped growing.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had major injury or narrowing of my urethra.
Select...
I have a bleeding disorder.
Select...
I am currently suffering from a severe infection.
Select...
I have open sores near my pelvis.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
urethral sphincter pressure

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment ArmExperimental Treatment1 Intervention
The investigators will test an alternative pattern of sacral root stimulation in individuals who are already implanted with the device. Study participants will act as their own controls.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Finetech-Brindley Sacral Anterior Roots Stimulation System
2022
Completed Early Phase 1
~10

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for spinal cord injury (SCI) include various forms of electrical stimulation, such as sacral root stimulation, which is being studied for its ability to promote bladder emptying by relaxing the urethral sphincter. These treatments work by delivering electrical impulses to specific nerves, which can help modulate neural activity and improve function. For instance, sacral root stimulation targets the nerves connected to the bladder, helping to coordinate bladder and sphincter activity, thus reducing the need for catheters. This is crucial for SCI patients as it can significantly improve their quality of life by reducing the risk of infections and enhancing bladder control.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,662 Total Patients Enrolled
Dennis Bourbeau, PhDPrincipal InvestigatorLouis Stokes VA Medical Center, Cleveland, OH
3 Previous Clinical Trials
21 Total Patients Enrolled

Media Library

Finetech-Brindley Sacral Anterior Roots Stimulation System (Device) Clinical Trial Eligibility Overview. Trial Name: NCT05214378 — Phase < 1
Spinal Cord Injury Research Study Groups: Treatment Arm
Spinal Cord Injury Clinical Trial 2023: Finetech-Brindley Sacral Anterior Roots Stimulation System Highlights & Side Effects. Trial Name: NCT05214378 — Phase < 1
Finetech-Brindley Sacral Anterior Roots Stimulation System (Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05214378 — Phase < 1
~1 spots leftby Dec 2025